Clarice Q F Leite
Overview
Explore the profile of Clarice Q F Leite including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
256
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Carvalho N, Pavan F, Sato D, Leite C, Arbeit R, Chimara E
J Antimicrob Chemother
. 2017 Dec;
73(4):862-866.
PMID: 29272470
Objectives: To define the genetic basis of clarithromycin resistance among isolates of the Mycobacterium abscessus group (MAG). Methods: We analysed 133 isolates identified as MAG. Species identification was confirmed by...
2.
Lopes E, Oliveira C, da Silva P, Eismann C, Suarez C, Menegario A, et al.
Int J Mol Sci
. 2016 May;
17(5).
PMID: 27213368
Cisplatin and its derivatives are the main metallodrugs used in cancer therapy. However, low selectivity, toxicity and drug resistance are associated with their use. The zinc(II) (Zn(II)) thiosemicarbazone complexes [Zn(atc-Et)₂]...
3.
Rodriguez Arce E, Mosquillo M, Perez-Diaz L, Echeverria G, Piro O, Merlino A, et al.
Dalton Trans
. 2015 Jul;
44(32):14453-64.
PMID: 26203896
In search of prospective agents against infectious diseases, 1,1'-bis(diphenylphosphino)ferrocene pyridine-2-thiolato-1-oxide M(ii) hexafluorophosphate compounds [M(mpo)(dppf)](PF6), where M = palladium or platinum, were synthesized and fully characterized in the solid state and...
4.
de Prince K, Pavan F, Sato D, Villegas W, Leite S, Leite C
Rev Port Pneumol
. 2015 May;
16SA:S83-8.
PMID: 25965936
No abstract available.
5.
Machado I, Marino L, Demoro B, Echeverria G, Piro O, Leite C, et al.
Eur J Med Chem
. 2014 Sep;
87:267-73.
PMID: 25261824
In the search for new therapeutic tools against tuberculosis and to further address the therapeutic potential of pyridine-2-thiol 1-oxide (Hmpo) metal complexes, two new octahedral [M(III)(mpo)3] complexes, with M =...
6.
Correia I, Adao P, Roy S, Wahba M, Matos C, Maurya M, et al.
J Inorg Biochem
. 2014 Sep;
141:83-93.
PMID: 25226436
Several mixed ligand vanadium and copper complexes were synthesized containing 8-hydroxyquinoline (8HQ) and a ligand such as picolinato (pic(-)), dipicolinato (dipic(2-)) or a Schiff base. The complexes were characterized by...
7.
de Souza P, Maia P, de Barros H, Leite C, Deflon V, Pavan F
Curr Clin Pharmacol
. 2014 Jan;
10(1):66-72.
PMID: 24433444
Tuberculosis (TB) is an infectious disease caused mainly by Mycobacterium tuberculosis (MTB) and still an important public health problem worldwide. Some factors like the emergence of multidrug resistant (MDR) and...
8.
Oliveira C, da S Maia P, Souza P, Pavan F, Leite C, Viana R, et al.
J Inorg Biochem
. 2013 Nov;
132:21-9.
PMID: 24188534
Through a systematic variation on the structure of a series of manganese complexes derived from 2-acetylpyridine-N(4)-R-thiosemicarbazones (Hatc-R), structural features have been investigated with the aim of obtaining complexes with potent...
9.
de Prince K, Sordi R, Pavan F, Santos A, Araujo A, Leite S, et al.
Braz J Microbiol
. 2013 Sep;
43(1):224-9.
PMID: 24031821
Our purpose was to determine the anti-Mycobacterium tuberculosis activity of the metabolites produced by the endophitic fungus Phomopsis stipata (Lib.) B. Sutton, (Diaporthaceae), cultivated in different media. The antimycobacterial activity...
10.
Pavan F, Poelhsitz G, da Cunha L, Barbosa M, Leite S, Batista A, et al.
PLoS One
. 2013 Jun;
8(5):e64242.
PMID: 23724039
Rifampicin, discovered more than 50 years ago, represents the last novel class of antibiotics introduced for the first-line treatment of tuberculosis. Drugs in this class form part of a 6-month...